Health Catalyst, Inc. reports developments tied to healthcare intelligence, data and analytics technology, and professional services for healthcare organizations. Company updates commonly cover operating results, revenue and Adjusted EBITDA guidance, and the use of AI-driven technology and domain expertise to support health systems across cost, clinical, and consumer performance.
Recurring news also includes leadership and board governance changes, shareholder-related board appointments, investor conference participation, and updates on strategic focus areas for its healthcare data platform, analytics applications, implementation, advisory, outsourcing, and improvement services.
Health Catalyst (Nasdaq: HCAT) announced the re-appointment of Stephen Grossbart, Ph.D., as a member of the National Quality Forum's Primary Care and Chronic Illness Standing Committee on Jan. 11, 2021. Grossbart has been on the committee since 2017, contributing to significant healthcare quality measures amid ongoing challenges like the coronavirus pandemic. The committee oversees important healthcare measures, crucial for improving treatment outcomes for chronic and infectious diseases.
Transformation Capital Partners has launched its oversubscribed growth equity fund, Transformation Capital Fund II, with $500 million in capital commitments. This fund targets investments in commercial-stage digital health companies aiming to improve healthcare efficiency and consumer access. The firm, managing over $800 million across its funds, leverages its deep industry expertise and extensive healthcare network to support digital health entrepreneurs. The pandemic has accelerated the adoption of digital health solutions across the sector, positioning Transformation Capital as a key partner for growth.
Health Catalyst (Nasdaq: HCAT) will participate in the 39th Annual J.P. Morgan Healthcare Conference from January 11-14, 2021. CEO Dan Burton and CFO Bryan Hunt will present on January 11 at 5:20 p.m. EST. The conference will be held virtually, allowing broader access to healthcare stakeholders. An audio replay of their presentation will be available on the company's investor relations website. Health Catalyst is known for its advanced data and analytics solutions aimed at improving healthcare outcomes through informed decision-making.
Health Catalyst, a leading healthcare data and analytics provider, will participate in three upcoming investor conferences. Executives Patrick Nelli, Bryan Hunt, and Adam Brown are scheduled to present at the following events: the Piper Sandler 32nd Annual Virtual Healthcare Conference on December 2, 2020; the Evercore ISI HealthCONx Conference on December 3, 2020, at 4:20 p.m. EST; and the Guggenheim Digital Health Virtual Conference on December 8, 2020, at 3:15 p.m. EST, with one-on-one meetings on December 9. More details are available on their investor relations page.
Health Catalyst, Inc. (Nasdaq: HCAT) reported its Q3 2020 financial results, showing a 20% year-over-year revenue increase to $47.2 million. Technology revenue grew by 32% to $28.0 million, while professional services revenue rose by 5%. Despite these gains, the company faced a net loss of $27.3 million, up from $21.4 million in Q3 2019. Adjusted EBITDA improved by 24%. Leadership changes were also announced, with Patrick Nelli becoming President, and Bryan Hunt appointed CFO, effective January 1, 2021. The company's outlook remains focused on growth and expanding customer relationships.
Health Catalyst (Nasdaq: HCAT) announced the promotion of Bryan Hunt to Chief Financial Officer effective January 1, 2021. Current CFO Patrick Nelli will transition to President, overseeing growth functions and client engagement. Nelli, instrumental in the company’s IPO, emphasized a commitment to enhancing healthcare transformation. Additionally, Jason Alger and Adam Brown have received promotions within the finance team. CEO Dan Burton expressed confidence in the leadership changes to drive HCAT's mission of improving healthcare through data and analytics.
Health Catalyst, a notable provider of data and analytics solutions for healthcare, announced that CFO Patrick Nelli and SVP Adam Brown will participate in the 29th Annual Credit Suisse Virtual Healthcare Conference on November 12, 2020, featuring a fireside chat at 2:45 p.m. ET. A live audio webcast and replay will be accessible on their investor relations website. Health Catalyst aims to enhance healthcare decisions through its cloud-based platform, which harnesses data from over 100 million patient records, driving improvements in clinical, financial, and operational outcomes.
Health Catalyst (Nasdaq: HCAT) announced a strategic partnership with Middle East Healthcare Company (MEA HCO) to service six Saudi German Hospitals in Saudi Arabia. This multi-year collaboration involves implementing Health Catalyst's DOS™ technology to enhance patient care and reduce costs. The partnership is supported by Topmed, a Dubai-based healthcare consulting firm, which will provide expertise in analytics and operational improvements. This collaboration aligns with Saudi German's commitment to advanced healthcare technologies and aims to drive measurable healthcare improvements.
Summary not available.
Health Catalyst (Nasdaq: HCAT) will announce its 2020 third quarter operating results on November 10, 2020, after market close. The company provides data and analytics technology to healthcare organizations, aiming for measurable healthcare improvement. A conference call will follow at 5 p.m. E.T., accessible by phone or via a live audio webcast. Health Catalyst's platform draws from over 100 million patient records, enabling clients to make data-informed decisions for operational and financial improvements.